Third Rock Ventures
Status
ACTIVE
Global HQ
Boston, United States
Countries of investment
- United States
Investment stages
- Seed
- Series A
Industries
- Life Sciences
- Biotechnology
- Health Tech
- AdTech
About
Third Rock Ventures is a venture capital firm that launches and builds life sciences companies, partnering closely with entrepreneurs to translate cutting-edge science into transformative medicines and therapies.
Third Rock Ventures is a venture capital firm that launches and builds life sciences companies, partnering closely with entrepreneurs to translate cutting-edge science into transformative medicines and therapies.
Investment Thesis
Third Rock Ventures is a biotech-focused venture capital firm that partners with founders to build companies by integrating science, medicine, business strategy, and operations in the earliest stages. With over $3.8 billion raised and a hands-on, entrepreneur-centered approach, the firm backs companies with “product engine” potential, capable of generating multiple therapies across disease areas.
Manager's Experience
Third Rock Ventures, launched in 2007 with over $3.8 billion raised, is led by a specialized team of scientific and business experts including venture partner Jigar Raythatha with 15 years’ operational biotech experience, joined by Mary Lynne Hedley, Steve Paul, Vyas Ramanan, and Courtney Wallace, known for their hands-on company-building model.
Team
Lisa Purcell
Paul Melone
Lee Venezia
Kevin Munnelly
Amanda Chan
Jigar Raythatha
Olie Luchitsky
Mary Lynne Hedley
Nasra Mohamed
Yashu Liu
Walter Kowtoniuk
David Moller
Portfolio
Merida Biosciences
Trace Neuroscience
Candid Therapeutics
Marea Therapeutics
Seaport Therapeutics